Literature DB >> 26189185

Multidrug-Resistant Pseudomonas aeruginosa Keratitis: Risk Factors, Clinical Characteristics, and Outcomes.

Jayesh Vazirani1, Siva Wurity2, Md Hasnat Ali3.   

Abstract

PURPOSE: To identify risk factors for multidrug-resistant Pseudomonas aeruginosa (MDR-PA) keratitis and to report clinical characteristics and outcomes of this infection.
DESIGN: Retrospective, case-control study. PARTICIPANTS: Ninety episodes of P. aeruginosa keratitis from a tertiary care eye institution from 2007 through 2014 were identified. Episodes of MDR-PA keratitis were taken as cases. Episodes of drug-sensitive P. aeruginosa keratitis during the same period were taken as controls.
METHODS: Chart review of cases and controls. Multidrug resistance was defined as resistance to 3 or more classes of antimicrobial drugs. Logistic regression analysis was used to determine association of baseline characteristics with multidrug resistance. Clinical characteristics and risk factors in each group also were compared. MAIN OUTCOME MEASURES: Risk factors for multidrug resistance, including age, gender, eye, duration of symptoms, topical steroid or lubricant ointment use, trauma, prior ocular surgery, presence of a compromised ocular surface, and bandage contact lens use.
RESULTS: Twenty-three episodes of MDR-PA keratitis (cases) and 67 episodes of drug-sensitive P. aeruginosa keratitis (controls) were identified. In the multivariate analysis, lubricant ointment use, presence of a compromised ocular surface, and bandage contact lens use were associated with MDR-PA keratitis. Antimicrobial resistance in the MDR-PA keratitis isolates was least for colistin and imipenem (56.52% each). Corneal perforation was more common in cases (52.17% [12 of 23]) than in controls (11.94% [8 of 67]; P = 0.0001). Cyanoacrylate glue application was required in 47.82% of cases (11 of 23), compared with 22.38% of controls (15 of 67; P = 0.031). Keratoplasty was more commonly required in cases (47.82% [11 of 23]) than in controls (20.89% [14 of 67]; P = 0.017).
CONCLUSIONS: Lubricant ointment use, a compromised ocular surface, and bandage contact lens use are associated with MDR-PA keratitis. Preservative-free lubricant ointment may act as a source or reservoir of infection. Outcomes are worse in MDR-PA keratitis compared with drug-sensitive P. aeruginosa keratitis.
Copyright © 2015 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26189185     DOI: 10.1016/j.ophtha.2015.06.007

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  27 in total

1.  Rose bengal photodynamic antimicrobial therapy to inhibit Pseudomonas aeruginosa keratitis isolates.

Authors:  Heather Durkee; Alejandro Arboleda; Mariela C Aguilar; Jaime D Martinez; Karam A Alawa; Nidhi Relhan; Jorge Maestre-Mesa; Guillermo Amescua; Darlene Miller; Jean-Marie Parel
Journal:  Lasers Med Sci       Date:  2019-12-23       Impact factor: 3.161

Review 2.  The persistent dilemma of microbial keratitis: Global burden, diagnosis, and antimicrobial resistance.

Authors:  Lawson Ung; Paulo J M Bispo; Swapna S Shanbhag; Michael S Gilmore; James Chodosh
Journal:  Surv Ophthalmol       Date:  2018-12-24       Impact factor: 6.048

3.  Red Eye: A Guide for Non-specialists.

Authors:  Andreas Frings; Gerd Geerling; Marc Schargus
Journal:  Dtsch Arztebl Int       Date:  2017-04-28       Impact factor: 5.594

4.  Development of a Broad-Spectrum Antimicrobial Combination for the Treatment of Staphylococcus aureus and Pseudomonas aeruginosa Corneal Infections.

Authors:  Michaelle Chojnacki; Alesa Philbrick; Benjamin Wucher; Jordan N Reed; Andrew Tomaras; Paul M Dunman; Rachel A F Wozniak
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

5.  Topical Glycyrrhizin Is Therapeutic for Pseudomonas aeruginosa Keratitis.

Authors:  Sandamali A Ekanayaka; Sharon A McClellan; Ronald P Barrett; Linda D Hazlett
Journal:  J Ocul Pharmacol Ther       Date:  2017-12-13       Impact factor: 2.671

6.  Interventions and Outcomes in Patients with Infectious Pseudomonas scleritis: A 10-Year Perspective.

Authors:  Sumayya Ahmad; Michelle Lopez; Marwan Attala; Anat Galor; Natalie A Stanciu; Darlene Miller; Leejee Suh; Thomas Albini; Victor L Perez; Carol L Karp; Janet L Davis; Eduardo Alfonso; Richard K Forster; Guillermo Amescua
Journal:  Ocul Immunol Inflamm       Date:  2017-10-17       Impact factor: 3.070

7.  Condensins are essential for Pseudomonas aeruginosa corneal virulence through their control of lifestyle and virulence programs.

Authors:  Hang Zhao; April L Clevenger; Phillip S Coburn; Michelle C Callegan; Valentin V Rybenkov
Journal:  Mol Microbiol       Date:  2022-02-09       Impact factor: 3.979

8.  Antimicrobial Blue Light Therapy for Infectious Keratitis: Ex Vivo and In Vivo Studies.

Authors:  Hong Zhu; Irene E Kochevar; Irmgard Behlau; Jie Zhao; Fenghua Wang; Yucheng Wang; Xiaodong Sun; Michael R Hamblin; Tianhong Dai
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

Review 9.  Foundational concepts in the biology of bacterial keratitis.

Authors:  Lawson Ung; James Chodosh
Journal:  Exp Eye Res       Date:  2021-06-05       Impact factor: 3.770

10.  Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.

Authors:  L Edward Clemens; Jesse Jaynes; Edward Lim; Satya S Kolar; Rose Y Reins; Hasna Baidouri; Samuel Hanlon; Alison M McDermott; Kathryn W Woodburn
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-12-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.